Capital Rx rebrands as Judi Health after securing $400M

Capital Rx has secured a $400 million investment, including a $252 million Series F round led by Wellington Management and General Catalyst. It is also rebranding as Judi Health to reflect its expansion beyond pharmacy benefits.

Editor's Pick

Top Story Capital Rx Rebrands as Judi Health After Securing $400M Investment Capital Rx has secured a $400 million investment, including a $252 million Series F round led by Wellington Management and General Catalyst. It is also rebranding as Judi Health to reflect its expansion beyond pharmacy benefits. Sponsored Helping to Transform Healthcare with Transparent Data Insights Presented by Claritev Claritev helps make healthcare clearer, smarter, and more affordable. With 40+ years of claims repricing expertise and powerful AI technology, we turn complex data into actionable insights. Our enterprise platform drives price transparency, optimizes networks, and reshapes benefit plan design—helping payers, providers, and employers deliver real value in healthcare. Learn more   Tell Us What You Love & Win $250! If you haven't yet, please take just a few minutes to complete our short, anonymous audience survey and share what you enjoy, what you don't, and what you'd like to see more of. As a thank you, you'll be entered for a chance to win a $250 Amazon gift card. Take Survey Now

Featured News

How Sutter Health Uses AI Agents to Handle Patients' Scheduling, Refills & Billing Questions Sutter Health is rolling out Hyro's AI agents, which give patients 24/7 support for things like scheduling, prescription refills and billing questions. These agents aim to make routine healthcare interactions faster and easier, while also freeing up staff to handle more complex cases and providing data insights to improve the overall patient experience. Ionis Pharma's Drug for Rare Disease With No Approved Therapies Meets Goals of Pivotal Study Ionis Pharmaceuticals plans a 2026 FDA submission for zilganersen as a treatment for Alexander disease, an ultra-rare inherited neurological disorder. The antisense oligonucleotide developer has been moving toward commercializing drugs on its own rather than seeking partners. Nudges, Not Information, For Engagement And Adoption Successful healthcare innovators harness behavioral science to achieve adoption and behavior change. From Products to Services: How Medical Device Companies Miss $100M+ Opportunities As trends around expanded decision-making ecosystems, consumer empowerment, data and intelligence, and economic uncertainty become everyday realities, the need for medical device companies to rethink and expand their business models becomes more urgent.

Video   Designing for women On MedCity FemFwd, Abbie Clary of CannonDesign shared her advice on how healthcare organizations should design for women.

Sponsored The Top-Rated Assistive Devices for Children With Sensory Processing Disorders Presented by Enabling Devices The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. Learn More.

Resources

MedCity Pivot Podcast: Price Transparency is the New North in the PBM World In this episode, a pharmacy benefit management executive and a pharmacy startup talk about why benefit verification, prior authorizations, and patient affordability still break the workflow and how smart integrations, real-time eligibility, and intuitive design can reduce friction for all involved. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe